Eleven faces of coronavirus disease 2019
- PMID: 32196678
- PMCID: PMC7228397
- DOI: 10.1111/all.14289
Eleven faces of coronavirus disease 2019
Abstract
Background and aims: The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has recently spread worldwide and been declared a pandemic. We aim to describe here the various clinical presentations of this disease by examining eleven cases.
Methods: Electronic medical records of 11 patients with COVID-19 were collected, and demographics, clinical manifestations, outcomes, key laboratory results, and radiological images are discussed.
Results: The clinical course of the eleven cases demonstrated the complexity of the COVID-19 profile with different clinical presentations. Clinical manifestations range from asymptomatic cases to patients with mild and severe symptoms, with or without pneumonia. Laboratory detection of the viral nucleic acid can yield false-negative results, and serological testing of virus-specific IgG and IgM antibodies should be used as an alternative for diagnosis. Patients with common allergic diseases did not develop distinct symptoms and severe courses. Cases with a pre-existing condition of chronic obstructive pulmonary disease or complicated with a secondary bacterial pneumonia were more severe.
Conclusion: All different clinical characteristics of COVID-19 should be taken into consideration to identify patients that need to be in strict quarantine for the efficient containment of the pandemic.
Keywords: SARS-CoV-2; allergic diseases; case reports; clinical characteristics; coronavirus disease 2019.
© 2020 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.
Figures
Comment in
-
COVID-19 and asthma: To have or not to have T2 inflammation makes a difference?Pulmonology. 2020 Sep-Oct;26(5):261-263. doi: 10.1016/j.pulmoe.2020.05.003. Epub 2020 May 19. Pulmonology. 2020. PMID: 32466999 Free PMC article. No abstract available.
Similar articles
-
Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip.PLoS One. 2020 Sep 17;15(9):e0237694. doi: 10.1371/journal.pone.0237694. eCollection 2020. PLoS One. 2020. PMID: 32941461 Free PMC article.
-
Value of Viral Nucleic Acid in Sputum and Feces and Specific IgM/IgG in Serum for the Diagnosis of Coronavirus Disease 2019.Front Cell Infect Microbiol. 2020 Aug 6;10:445. doi: 10.3389/fcimb.2020.00445. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 32850506 Free PMC article.
-
Antibody responses to SARS-CoV-2 in patients with COVID-19.Nat Med. 2020 Jun;26(6):845-848. doi: 10.1038/s41591-020-0897-1. Epub 2020 Apr 29. Nat Med. 2020. PMID: 32350462
-
Coronavirus global pandemic: An overview of current findings among pediatric patients.Pediatr Pulmonol. 2020 Dec;55(12):3252-3267. doi: 10.1002/ppul.25087. Epub 2020 Oct 7. Pediatr Pulmonol. 2020. PMID: 32965785 Free PMC article. Review.
-
Diagnosis and treatment of coronavirus disease 2019 (COVID-19): Laboratory, PCR, and chest CT imaging findings.Int J Surg. 2020 Jul;79:143-153. doi: 10.1016/j.ijsu.2020.05.018. Epub 2020 May 15. Int J Surg. 2020. PMID: 32422384 Free PMC article. Review.
Cited by
-
Dynamic changes of hematological and hemostatic parameters in COVID-19 hospitalized patients: Potential role as severity biomarkers for the Chilean population.J Med Biochem. 2024 Jun 15;43(4):556-564. doi: 10.5937/jomb0-47588. J Med Biochem. 2024. PMID: 39139154 Free PMC article.
-
The Effect of Coronavirus Disease 2019 on the Quality of Associated Care in Patients with Gastric Cancer.Middle East J Dig Dis. 2024 Jan;16(1):12-22. doi: 10.34172/mejdd.2024.363. Epub 2024 Jan 31. Middle East J Dig Dis. 2024. PMID: 39050096 Free PMC article. Review.
-
The liver-to-spleen ratio is a risk factor predicting oxygen demand in COVID-19 patients.Infect Med (Beijing). 2023 Jun;2(2):105-111. doi: 10.1016/j.imj.2023.04.002. Epub 2023 Apr 20. Infect Med (Beijing). 2023. PMID: 38013740 Free PMC article.
-
A cross-sectional study in critically ill patients affected by COVID-19 in an intensive care unit: would Acinetobacter baumannii resistant to carbapenems be the biggest villain?Access Microbiol. 2023 Oct 18;5(10):000542.v3. doi: 10.1099/acmi.0.000542.v3. eCollection 2023. Access Microbiol. 2023. PMID: 37970088 Free PMC article.
-
Interleukin-6 and Its Soluble Receptor Complex in Intensive Care Unit COVID-19 Patients: An Analysis of Second Wave Patients.Pathogens. 2023 Oct 20;12(10):1264. doi: 10.3390/pathogens12101264. Pathogens. 2023. PMID: 37887780 Free PMC article.
References
-
- World Health Organization (WHO) . Coronavirus disease (COVID‐2019) situation reports. https://www.who.int/emergencies/diseases/novel‐coronavirus‐2019/situatio.... Accessed March 11, 2020.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous